UK’s QuantuMDx Invests £11M To Bring Forward Launch Of Rapid, Point-Of-Care DNA Analyzer
The COVID-19 pandemic has accelerated development of another new molecular diagnostic technology.
You may also be interested in...
As far as aspirations go, QuantuMDx is setting its sights high. The UK diagnostics start-up is still in the early stages of product development but one thing CEO Elaine Warburton has set her mind on is ensuring the company’s “lab-in-your-hand” device will emulate the sleek, simple and user-friendly designs that are iconic of the information technology giant Apple.
The deal combines two of the largest providers of sterilization and infection-prevention products to create a $4bn-plus-revenue business.
One of the few silver linings in a tumultuous year dominated by a global pandemic was the huge boost given to the diagnostics and telehealth sectors. But while new technologies for rapid testing for COVID-19 and remote monitoring tools dominated the headlines, there were also key developments in robotic surgery, early-stage cancer testing and cardiac arrhythmia treatment. Here are Medtech Insight’s most popular R&D stories in 2020.